IMGN : Analysis & Opinions

  1. Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen ...

    December 24, 2014
    Will Express Scripts' announcement regarding AbbVie's (ABBV) Viekira Pak lead to a pricing war in the hepatitis C virus (HCV) ...
  2. ImmunoGen/Roche's Kadcyla Fails in Study, Shares Plunge - Analyst ...

    December 22, 2014
    ImmunoGen (IMGN) and partner Roche's Kadcyla failed to meet the primary endpoint in a phase III study conducted in HER2-positive ...
  3. Roche Oncology Candidate Progresses - Analyst Blog

    October 2, 2012
    Roche Holdings Ltd. (RHHBY) recently announced additional results from its phase III EMILIA study, which was conducted with ...
  4. Eli Lilly Among Healthcare's Biggest Movers on August 27, 2012

    August 27, 2012
    The market is on the rise this morning. The Nasdaq is up 0.5%; the S&P 500 has risen 0.3%; and the Dow has climbed 0.1%. ...
  5. Another Setback For Roche Is Bad News For ImmunoGen

    August 27, 2010
    Roche suffers another setback to its key cancer franchise, while ImmunoGen faces a major delay in royalty payments.
Trading Center